Condition 1: Succinylcholine Chloride. Condition 2: Sodium Thiopental. Condition 3: Ketamine. Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents], Skeletal muscle relaxants [neuromuscular blocking agents] Poisoning:Intravenous anaesthetics Poisoning: Other and unspecified general anaesthetics
Conditions
Interventions
Intervention 1: First group received A packages included succinylcholine (0.5 mg/kg) and Sodium thiopental (2 mg/kg).Drugs inject IV and bolusly. Intervention 2: Second group received B packages incl
Treatment - Drugs
First group received A packages included succinylcholine (0.5 mg/kg) and Sodium thiopental (2 mg/kg).Drugs inject IV and bolusly.
Second group received B packages included succinylcholine (0.5 mg/kg) and Ketamine (1mg/kg).Drugs inject IV and bolusly.
Sponsors
Vice Chancellor for Research of Isfahan University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 25 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients candidates receiving electroconvulsive therapy seizures; Subjects younger than 25 years old with American society of anesthesiology physical status class 1 (ASAI) . Exclusion criteria: After receiving the shock, hemodynamic unstable.; patients with seizure duration more than 90 seconds less than 20 seconds;After receiving the shock? tracheal intubation indicated; drugs used to react strongly.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Back to Breathe Spontaneously. Timepoint: From the end of seizure to respiration. Method of measurement: Second with Timer.;Seizure Duration. Timepoint: From the start to the end of seizure. Method of measurement: Second with Timer.;Blood Pressure. Timepoint: 1, 5 and 10 seconds after the shock. Method of measurement: mmhg with Manometer.;Pulse. Timepoint: 1, 5 and 10 seconds after the shock. Method of measurement: Beat per minute with Pulse Oximeter.;O2 saturation. Timepoint: 1, 5 and 10 seconds after the shock. Method of measurement: Percent with Pulse Oximeter.;Recovery Duration. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with Timer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: After recovery. Method of measurement: Ask the patient.;Cough. Timepoint: After recovery. Method of measurement: Ask the patient.;Nausea and Vomiting. Timepoint: After recovery. Method of measurement: Ask the patient.;Laryngospasm. Timepoint: After recovery. Method of measurement: Evaluation of patient such as breathing and o2 sat.;Muscle Pain. Timepoint: After recovery. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed